Predicting Prolonged Mechanical Ventilation after Endovascular Treatment for Acute Vertebrobasilar Artery Occlusion
Qiankun Cai,Minying Hong,Yingjie Xu,Shuai Zhang,Zhixin Huang,Pengfei Xu,Xianjun Huang,Shufen Liu,Zhengping Huang,Lichao Ye,Jixing Chen,Hongyu Huang,Feng Zheng,Wen Sun
DOI: https://doi.org/10.1101/2023.12.05.23299562
2023-01-01
Abstract:Background Patients with acute vertebrobasilar artery occlusion (VBAO) after endovascular treatment (EVT) frequently require mechanical ventilation (MV). This study aims to develop and validate a predictive score for prolonged mechanical ventilation (PMV) in patients with VBAO after EVT. Methods The derivation cohort prospectively recruited acute VBAO patients undergoing EVT from four comprehensive stroke centers (CSCs) in China. PMV was defined as continuous MV for ≥96 hours. Two multivariable logistic regressions were performed to predict predictive models based on whether adding radiographic results at follow-up. The performance of two models was evaluated for discrimination, calibration, and clinical utility. A validation cohort of 444 patients from acute Posterior circulation ischemic Stroke registry was enrolled to validate two models. Results The derivation cohort consisted of 498 patients from four CSCs, among whom 204 (41.0%) required PMV. Reperfusion status, National Institutes of Health Stroke Scale scores, collateral circulation status, history of atrial fibrillation, fasting blood glucose, circulation insufficiency, the presence of malignant cerebellar edema, and symptomatic intracranial hemorrhage at follow-up imaging were found to be independent predictors of PMV in multivariable logistic regression. These variables were combined to create the basic and radiographic PAIRS scores. The basic PAIRS and radiographic PAIRS scores demonstrated adequate discrimination in derivation cohort (C-index, 0.77 [95%CI 0.73 to 0.81] and 0.80 [95%CI 0.77 to 0.84]), as well as the validation cohort (C-index, 0.70 [95%CI 0.65 to 0.75] and 0.75 [95%CI 0.70 to 0.80]), and had well-fitted calibration plot for both cohorts. Decision curve analysis showed that both PAIRS scores had satisfied net benefit in predicting PMV across various thresholds. Conclusions The PAIRS scores provide adequate accurate predictions of PMV in VBAO patients after EVT. These findings can assist patient families and caregivers in better understanding the treatment trajectory. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial http://www.chictr.org.cn/; unique identifier: ChiCTR2000033211 ### Funding Statement This work was supported by Startup Fund for scientific research of Fujian Medical University (No XJ2021014001), Science and Technology Program of Guangzhou (No 202201020359), Key Research and Development Plan Projects of Anhui Province (No 202104j07020049). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was approved by ethics committee of USTC: No 2020-40; Guangdong Second Provincial General Hospital: No 2020-KY-KZ-100-03; the Second Affiliated Hospital of Fujian medical University: No 2020-339; The Affiliated hospital of Yangzhou University: No 2020-153. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes The data that support the finds of this study are available from the corresponding author on reasonable request.